Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Rhino mice show significant meibomian gland changes, making them a potential model for studying gland disorders.

The nanoplatform helps heal wounds by balancing bacteria-killing and inflammation-reducing functions.

Resveratrol activates the Nrf2 pathway in human skin, significantly increasing the production and distribution of the antioxidant glutathione.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

The new palladium catalyst is effective and reusable for making pharmaceutical ingredients.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Repetin is a protein involved in skin and hair development, binding calcium and compensating for other proteins when needed.

Ribonucleotide excision repair is crucial to prevent skin cancer.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

A new skin model from hair follicles is a safer, simpler alternative for skin tests.

Zinc is crucial for nutrition, especially in patients with specific health conditions, and requires careful supplementation and monitoring.

Efficient enzyme function relies on specific residue interactions and structural coordination.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

17β-estradiol can reduce inflammation in the skin.

Targeting Keratin 17 may help overcome cancer therapy resistance.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Dynamet Technology won an award for its advanced titanium technology.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.